Applied Genetic Chief Medical Officer to step down
Applied Genetic Technologies announced that Theresa Heah, M.D., Chief Medical Officer, has resigned from the company to pursue other opportunities. Given that the clinical results for the upcoming data releases are still being processed at external vendors and not yet available for internal review, Dr. Heah's resignation does not relate to any knowledge of pending results. Dr. Heah has agreed to stay with the company until the end of the year to support the up-coming data analysis. In addition, Dr. Heah's departure does not affect the company's previously announced guidance on the timing of data reporting from its ongoing Phase 1/2 clinical trials in patients with X-linked retinitis pigmentosa and achromatopsia.